gastrointestinal block

Slides:



Advertisements
Similar presentations
The H pylori Story – Helicobacter pylori through the ages
Advertisements

Nursing Care of Patients WithUpper GI Disturbances
Role of H.pylori in Peptic Ulcer and drugs used in Treatment Dr. Abdulaziz al-Khattaf.
Peptic ulcer.
Microbe of the Week Mycobacterium marinum The aquarium or fish tank disease,first reported in 1962 Rare but important if not treated Living example-Karen.
Peptic ulcer disease.
An infectious bacterium: Helicobacter pylori Tony 10/07/2005.
Treatment of H Pylori -Peptic Ulcer Disease By Prof. Hanan Hagar Department of Physiology and Pharmacology.
PEPTIC ULCER DISEASE NRS452 Norhaini Majid.
Case Study 67 Pathogenic Bacteriology 2009
(And Campylobacter-like species)
Peptic Ulcer Disease. Peptic ulcer  refers to erosion of the mucosa lining any portion of the G.I. tract.  It is defined as : A circumscribed ulceration.
Peptic Ulcer and Helicobacter pylori infection:
H PYLORI BY MARUF A.. Historical Background  Marshall and Warren identified and subsequently cultured the gastric bacterium, Campylobacter pyloridis,
Gastric Acid Secretion 1. Acid synthesis – regulated by 3 transporters Lumen Plasma Parietal cell.
Clinical Microbiology (MLCM- 201) Prof. Dr. Ebtisam. F. El Ghazzawi. Medical Research Institute (MRI) Alexandria University.
Biology of Disease CH0576 Peptic Ulceration Role of H. pylori.
Helicobacter First one discovered in 1983 by Drs. Barry Marshall and J. Robin Warren Originally classified as a Campylobacter.
PUD Peptic Ulcer Disease Prince Sattam Bin AbdulAziz University College Of Pharmacy Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of.
CAMPYLOBACTER & Helicobacter Gram negative curved rods Gram negative curved rods Dr. H.Gh.Safaei.
Peptic Ulcer Disease Dr. Wael H. Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival Alain P. Gobert, David J. McGee, Mahmood.
CampylobacteriaceaeCampylobacteriaceae Campylobacter Heliobacter Heliobacter (Gram-negative curved rods)
Role of H.pylori in Peptic Ulcer and drugs used in Treatment Dr. Abdulaziz al-Khattaf.
Diagnosis of PUD.
GASTROINTESTINAL DISEASES By: Jenny Ruiz 10/13/09 – TR 7pm.
Role of H. pylori in Peptic Ulcer and drugs used in Treatment Dr. Fawzia Alotaibi.
Najran University College of Medicine Enterobacteriaecae 2 BY Dr. Ahmed Morad Asaad Professor of Microbiology.
H.Pylori and PUD Yousif A. Qari,MD,ABIM,FRCPC Cosultanat Gastroenterologist King Abdulaziz University Hospital Jeddah,Saudi Arabia.
VIBRIO CHOLERAE CHOLERA. CHARACTERISTICS GRAM-NEGATIVE, COMMA SHAPED BACILLI MOTILE – POLAR FLAGELLA OXIDASE – POSITIVE CATALASE – POSITIVE ALKALNE PH.
CASTRIC ULCER CASE A 72-year-old male was seen by his physician because of epigastric distress shortly after eating a meal, and occasionally during the.
Role of H.pylori in Peptic Ulcer and drugs used in Treatment Dr. Fawzia ALOtaibi.
Peptic Ulcer and Helicobacter pylori Infection. History: In 1983, Barry Marshall and Robin Warren, reported that H. pylori is associated with chronic.
Peptic ulcers are open sores in the mucosa of the lower oesophagus (esophageal ulcer), duodenum (dudenal ulcer ) and stomach (gastric ulcers). Caused.
Genus Compylobacter Helicobacter pylori Objectives Describe the general structure, biochemical and antigenic structure of Compylobacter Illustrate the.
THE GENUS HELICOBACTER Gram –ve rod, curved microaerophilic oxidase + strong urease activity At least 22 species included in this genus Majority colonize.
Objectives By the end of this lecture the student must be:
Helicobacter pylori and gastric ulcers. Helicobacter pylori (H. pylori) is a spiral shaped bacterium that lives on the lining of the stomach; inflammation.
HELICOBACTER PYLORI Millions of years old microorganism of mankind Causes a spectrum of diseases Obviously requires high priority Treatment strategies.
Helicobacter pylori and Gastric Lymphoma
Clinical Practice Helicobacter pylori Infection Kenneth E.L. McColl, M.D. N Engl J Med Volume 362(17): April 29, 2010.
Ulcers & Stomach Cancer
Department: Microbiology
GI For Rehabilitation.
Fatimah Abdullah 6th year MS, KFU
Gastroesophageal Reflux Disease affecting the upper gastrointestinal tract. 10% of the population experience Heartburn is the cardinal symptom.
Role of H.pylori in Peptic Ulcer and drugs used in Treatment
Helicobacter pylori eradication prior bariatric/metabolic surgery
Stomach cancer.
Peptic ulcer disease-2 Clinical presentation & investigations
Gastritis.
Molecular characterization and antibiotic resistance profiles of H
Done by: Tala Alsaket Ruba Al-mgableh Salam Hiasat Lujain Arabiat
Dyspepsia & Peptic Ulcer
PUD By Alaina Darby.
Qassim J. odda Master in adult nursing
Role of H.pylori in Peptic Ulcer and drugs used in Treatment
LECTURE: Helicobacter Pylori
Gastrointestinal pathogens: Helicobacter pylori
Dyspepsia & Peptic Ulcer
CASE A 55 years old man presents with a history of worsening epigastric pain with a burning sensation, since 6 months. He notices that,the pain is worse.
GASTRITIS By : BILAL HUSSEIN.
HELICOBACTER PYLORI INFECTION
Peptic Ulcer and Helicobacter pylori infection:
Care of Patients with Stomach Disorders
-جرثومة المعدة-.
Role of H.pylori in Peptic Ulcer and Drugs Used in Treatment
Campylobacter Microbiology properties Curved (comma- or S-shaped)
Presentation transcript:

gastrointestinal block Role of H pylori in peptic ulcer and drugs used in treatment By Abdallah Mohamed Microbiology department

Objective To define peptic ulcer disease and assess its distribution among patients. To briefly indicate the signs and symptoms.   To know impact of the discovery of H.pylori on the change of diagnosis and management of peptic ulcer. To understand the various gastric and duodenal diseases caused by H.pylori. To learn laboratory characteristics of H. pylori and its identification and diagnosis. To know the pathophysiology of H.pylori inside the stomach and duodenum. To learn the prevention methods used for H.pylori infection. To explore and learn the epidemiology and transmission ways of the disease. Finally, to know the management and treatment regiments used for eradication of H.pylori. .

1983-discovered by Warren and Marshall in Australia introduction 1983-discovered by Warren and Marshall in Australia Discovery revolutionised the treatment of duodenal and gastric ulcers Gram-negative spiral bacillus Fastidious in terms of growth requirements strictly micro-aerophilic require C02 for growth on charcoal medium Has a tuft of sheathed unipolar flagella; specially adapted to colonies on mucous membranes

Epidemiology Around 50% of world’s population harbor H pylori. Third world has more rate of infection. Infections are usually acquired at childhood. Poor sanitary conditions contribute to high rates. In USA high prevalence among African-American and Hispanic population-Due to socioeconomic status. Higher hygiene standards and widespread use of antibiotics behind lower rate of infection in the west. Overall frequency of H pylori infection is declining. Prevalence varies greatly among countries and population groups. اسم ورقم المقرر – Course Name and No. 4/21/2019

Transmission Contagious with an unknown route of transmission . Person to person (oral to oral or fecal-oral) route. Transmission occur mainly within families or community. Fecal-oral route of infection occur by ingestion contaminated food or water due poor hygiene. Using same spoons, forks and tooth brushes and kissing children mouth to mouth increases oral-oral route of infection. Gastric antrum is the most favoured site. Present in the mucus that overlies the mucosa. اسم ورقم المقرر – Course Name and No. 4/21/2019

Peptic ulcer disease (PUD): H. pylori causes an inflammatory response with neutrophils, lymphocytes, plasma cells, and macrophages within the mucosal layer and causes epithelial cell degeneration and injury اسم ورقم المقرر – Course Name and No. 4/21/2019

اسم ورقم المقرر – Course Name and No. 4/21/2019

Helicobacter pylori is found closely associated with gastric mucosa and causes chronic active gastritis, gastric and duodenal ulcer (Peptic ulcer) and could develop adenocarcinoma and gastric mucosa-associated lymphoid tissue (MALT) lymphoma. اسم ورقم المقرر – Course Name and No. 4/21/2019

Signs and symptoms of a peptic ulcer can include one or more of the following: abdominal pain, classically epigastric strongly correlated to mealtimes. In case of duodenal ulcers the pain appears aboutthree hours after taking a meal; waterbrash (rush of saliva after an episode of regurgitation to dilute the acid in esophagus - although this is more associated with gastroesophageal reflux disease); nausea and copious vomiting; bloating and abdominal fullness

loss of appetite and weight loss; cont loss of appetite and weight loss; hematemesis (vomiting of blood); this can occur due to bleeding directly from a gastric ulcer, or from damage to the esophagus from severe/continuing vomiting. melena (tarry, foul-smelling feces due to presence of oxidized iron from hemoglobin); اسم ورقم المقرر – Course Name and No. 4/21/2019

Pathophysiology To colonize the stomach, H pylori must survive acidity. Using flagella, H pylori moves through stomach lumen and drill into the mucoid lining of stomach. Produces adhesions that binds to the epithelial cells. Produces large amounts of urease enzyme that break down urea into co2 +ammonia. This in-turn neutalizes gastric acid. Ammonia is toxic to epithelial cells along with proteases, vacA protein and phospholipases produced by H pylori and could damage epithelial cells.

Pathophysiology- cont Colonization of stomach or duodenum results in chronic gastritis (inflammation of stomach lining). Inflammation stimulate more production of gastric acid. This leads to gastric and duodenal ulcers, atrophy and later cancer. CagA protein was found to contribute to peptic ulcer. Neutrophil-Activating Protein (NAP) recruits neutrophils to gastric mucosa causing inflammation. Free radical production in the gastric lining due to H pylori , increases host cell mutation. H pylori induces the production of TNF-α(tumor necrosis factor alpha) and Interleukin 8 that leads to host cells mutation. اسم ورقم المقرر – Course Name and No. 4/21/2019

اسم ورقم المقرر – Course Name and No. 4/21/2019

Laboratory characteristics non invasive testing Culture: on blood or chocolate agar in a moist microaerophilic atmosphere. For isolation from clinical specimens, use campylobacter selective medium. Small colonies grow after 5-7 days at 37˚C.

Antigen Detection Test in Stool Detection of H.pylori antigen in stool appropriate test in patients with H.pylori patients Absence of antigen indicates cure of Infection after Chemotherapy

Urea Breath Test In this test test 13C or 14C C labelled urea is ingested labelled urea is ingested by patients If H.pylori is present the urease activity generates labelled Co that can be detected in the patients exhaled breath اسم ورقم المقرر – Course Name and No. 4/21/2019

Invasive testing Histological examination of biopsy specimens of gastric/duodenal mucosa take at endoscopy

Prevention Eradication of infection will improve symptoms: Such as (dyspepsia, gastritis, peptic ulcer and cancer). Vaccination: Promising results with studying adjuvant, antigens. Determining route of immunization (oral or intramuscular). Dietary methods: (eating broccoli, cabbage, honey, and drinking green tea). Proper sanitation and clean sources of drinking water).

Antibiotic sensitivity In vitro H.pylori is sensitive to amoxycillin, tetracycline, metronidazole, macrolides (clarithromycin). However, in vivo their efficacy is often poor due to the low pH of the stomach, their failure to penetrate the gastric mucus and the low concentration of antibiotic obtained in the mucosa of the stomach. Recently , Metronidazole in developing countries is becoming resistance (80-90%).

First line therapy clarithromycin 500mg b.d. + amoxicillin 1000mg or metrodiazole 500mg minimum of 7 days In case of failure Second line therapy bismuth subsalicylate/subcitrate 120mg QDS (once a day) + metronidazole 500mg t.d.s. (3 times a day)+ tetracycline 500mg for a minimum of 7 days If bismuth is not available, PPI based triple therapies should be used Subsequent failures should be handled on a case-case basis. Patients failing second-line therapy in primary care should be referred

Quadruple Therapies 7days regimen of combination of Amoxycillin , metronidazole, Ranitidine Bismuth Citrate and proton pump inhibitor (Omeprazole) have shown to increase the eradication rate up to 98%. Unfortunately it was followed by side effects such as vaginal candidiasis in 10% of women and Pseudomembranous colitis in 11% of patients.

Prevention Eradication of infection will improve symptoms: Such as (dyspepsia, gastritis, peptic ulcer and cancer). Vaccination: Promising results with studying adjuvant, antigens. Determining route of immunization (oral or intramuscular). Dietary methods: (eating broccoli, cabbage, honey, and drinking green tea). Proper sanitation and clean sources of drinking water). اسم ورقم المقرر – Course Name and No. 4/21/2019

End Thank you four your attention Any question